Pembrolizumab Plus Epacadostat, Pembrolizumab Monotherapy, and the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-669/ECHO-304)
Incyte Corporation
Incyte Corporation
GERCOR - Multidisciplinary Oncology Cooperative Group
Merck Sharp & Dohme LLC
City of Hope Medical Center
GlaxoSmithKline
Merck Sharp & Dohme LLC
Bristol-Myers Squibb
Wake Forest University Health Sciences
University of Chicago
Eli Lilly and Company
Icahn School of Medicine at Mount Sinai
Memorial Sloan Kettering Cancer Center
Masonic Cancer Center, University of Minnesota
University of Michigan Rogel Cancer Center
Radiation Therapy Oncology Group
SCRI Development Innovations, LLC
Case Comprehensive Cancer Center